Related Experiment Video
Updated: Jun 18, 2025

09:41
Chromatin Immunoprecipitation from Dorsal Root Ganglia Tissue following Axonal Injury
Published on: July 20, 2011
16.1K
Transcriptional reprogramming post-peripheral nerve injury: A systematic review.
R Hayward1, S Moore1, D Artun1
1Nociception Group, Department of Surgery and Cancer, Division of Anaesthetics, Pain Medicine and Intensive Care, Chelsea and Westminster Hospital Campus, Imperial College London, 369 Fulham Road, London SW10 9FJ, UK.
Neurobiology of Disease
|August 3, 2024
Summary
Peripheral nerve injury causes neuropathic pain by altering sensory neuron gene expression. Understanding these transcriptional changes may lead to new pain relief treatments.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Neuropathic pain, characterized by hyperalgesia and allodynia, arises from somatosensory nervous system damage.
- Peripheral nerve injury triggers transcriptional reprogramming in sensory neurons, increasing spinal nociceptive signals.
- Current treatments for neuropathic pain are often ineffective and cause adverse effects, highlighting an unmet medical need.
Purpose of the Study:
- To analyze transcriptional changes in peripheral nerve injury-induced neuropathy.
- To identify common functional profiles and key genes involved in neuropathic pain development.
- To explore potential therapeutic targets for novel analgesics.
Main Methods:
- Conducted a literature search identifying 65 papers on transcriptomic changes post-peripheral nerve injury.
- Performed gene ontology enrichment analysis on transcriptional data.
- Focused on genes within 'sensory perception of pain' (GO:0019233) and regeneration-associated genes.
Main Results:
- Identified significant transcriptional alterations in ion channels, receptors, and neurotransmitters related to nociception.
- Revealed subtype-specific transcriptional reprogramming in peripheral sensory neurons.
- Highlighted the role of temporal transcriptional programs in regulating hypersensitivity.
Conclusions:
- Understanding the temporal transcriptional reprogramming following nerve injury is crucial for developing targeted neuropathic pain therapeutics.
- Identifying specific genes and pathways offers a promising avenue for novel analgesic drug development.
- Targeting these mechanisms could lead to effective neuropathic pain management with fewer side effects.
Related Concept Videos
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Neurogenesis and Regeneration of Nervous Tissue
750
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
750

